MJBizDaily International Newsletter

Get our international newsletter

More Exclusive Features

Deal Watch: Hemp, infused products and devices see notable gains in M&A activity

While overall merger and acquisition investment in the North American cannabis industry has been far outpacing that of 2018, several sectors have posted notable increases so far this year.

Three sectors – hemp, infused products and extracts, and consumption devices – have seen M&A activity values at $1.42 billion this year.

Read More

EXCLUSIVE: Lesotho planning overhaul of medical cannabis rules

A revamped round of regulations is in the works in Lesotho that would spell out new guidelines for awarding medical cannabis business licenses in the southern African nation, Marijuana Business Daily has learned. While many of the proposals are more business-friendly than the current rules, some of the draft amendments would effectively erect barriers for […]

Read More

Canadian bank’s ‘unfair’ cannabis fees add to financial hurdles for lottery hopefuls

One of Canada’s top lenders is charging prospective cannabis business owners thousands of dollars for a routine review of financial documents, imposing an added cost on entrepreneurs who want to enter Ontario’s upcoming lottery for the right to open a marijuana retail store. The Bank of Montreal (BMO) is charging potential clients 3,000 Canadian dollars […]

Read More

CannTrust chaos continues with ousting of CEO, chairman resignation

Ontario, Canada-based licensed producer CannTrust fired its chief executive, Peter Aceto, “with cause” Thursday amid an ongoing scandal involving unlicensed cannabis cultivation that has enveloped the marijuana industry in Canada for weeks. The company also demanded, and received, the resignation of its longtime chairman, Eric Paul. “The investigation into the company’s noncompliance with Health Canada regulations […]

Read More

Israel throws medical cannabis industry curveball with new price control plan

The Israeli Ministry of Health is introducing a price control plan for medical cannabis that does not include a reimbursement mechanism, disappointing industry experts who had hoped the medicine would be added to the country’s “basic health basket.” The new pricing plan is expected to result in bigger monthly bills for frequent consumers, which analysts say could […]

Read More

Deal Watch: Big players are behind marijuana M&A deals

Last week wasn’t the busiest for completed M&A deals in the cannabis industry, but some notable transactions were concluded – including one involving a well-established multistate operator (MSO) and another a relatively new but fast-emerging player on the scene.

Read More

Aurora sole winner of Italian medical cannabis tender, but average price is low by most standards

Aurora Deutschland – the German subsidiary of Alberta-based Aurora Cannabis – won all three “lots” to supply Italy with a total of 400 kilograms (880 pounds) of medical marijuana over two years, the Italian government announced. But the award may come at a cost for the Canadian company: The average price it offered – 1.73 euros […]

Read More

German sales of insurance-covered medical cannabis continue upward trend

Sales of insurance-covered medical cannabis continued to increase during the first quarter of 2019 in Germany, the largest market outside North America. In the first three months of the year, sales of reimbursed cannabis products totaled 24.5 million euros ($27.5 million), an increase of 7% from the fourth quarter of 2018, according to government data. […]

Read More